1. Update on the Use of Vonoprazan: A Competitive Acid Blocker
David Y. Graham 
Gastroenterology 
Volume 154, Issue 3, Pages (February 2018)
DOI: /j.gastro
Copyright © 2018 AGA Institute Terms and Conditions

2. Figure 1
Example of the effects of clarithromycin resistance on the overall cure rate with 7-day vonoprazan clarithromycin triple therapy In this example, the cure rate with clarithromycin-susceptible and -resistant infections is 93% and 80%, respectively. A prevalence of clarithromycin resistance of 40% results in an 87% overall cure rate. The treatment-specific cure rates would be 80%, irrespective or the presence or absence of clarithromycin; the incremental increase with clarithromycin would be 7% and 13% would fail despite amoxicillin and clarithromycin.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2018 AGA Institute Terms and Conditions